🔬 International Clinical Trials Day OncoRes Medical is marking International Clinical Trials Day today. Quick fact > International Clinical Trials Day is celebrated globally on 20 May to commemorate when Scottish Surgeon James Lind commenced what is recognised as the first ever randomised clinical trial in scurvy in 1747, laying the foundations for modern clinical research. 277+ years later, clinical research remains an important part of the global economy and healthcare system. For our growing business, it is vital – we are developing technology (QME – Quantitative Micro-Elastography) to change the way surgeons perform cancer surgery, supercharging the surgeons’ sense of touch. We are starting in Breast Cancer, where up to a third of patients need two or more invasive surgeries to remove all of the cancer. Our device is currently in clinical trials to test its merits in practice. So far, we have completed three clinical trials at Fiona Stanley Hospital in Western Australia; and a multisite trial has just commenced at the Peter MacCallum Cancer Centre and The Royal Melbourne Hospital in Victoria, and Fiona Stanley Hospital and Fremantle Hospital in Western Australia. These trials have supported development of our product and will support applications to the TGA and FDA. They have many moving parts – but the end goal is so worth it. Measured, ethical innovation, with the capacity to bring incredible, patient-first innovation to the operating table. #clinicaltrials #oncology # medtech #innovation #breastcancer #breastconservation #breastconservationsurgery #lumpectomy #patientsfirst #patientoutcomes
OncoRes Medical’s Post
More Relevant Posts
-
In the fight against breast cancer a multidisciplinary approach is essential in ensuring the best outcomes for patients. This approach involves close collaboration among oncologists, surgeons, radiologists, pathologists and other specialists to develop a personalized treatment plan. From accurate diagnosis to appropriate treatment and management of side effects, the multidisciplinary team provides a comprehensive range of expertise and resources to improve patients’ quality of life and optimize clinical outcomes. Through collaboration among specialists the best therapeutic strategies can be identified, unnecessary or aggressive treatments can be avoided and personalized care can be ensured for each patient. In an era where medical research iand technology are advancing rapidly, the multidisciplinary approach remains key in the fight against breast cancer offering hope, support and treatment for patients and their families. #BreastCancerAwareness #MultidisciplinaryApproach #OncologyCare #SurgicalOncology #RadiationTherapy #PathologyInsights #PersonalizedTreatment #ClinicalOutcomes #MedicalAdvancements #AdvancedCareSolutions #SupportingSurvivors #InnovativeTherapies #StrengthInUnity #TogetherAgainstCancer #HopeAndSupport MedEuropa
To view or add a comment, sign in
-
REGISTER NOW for our upcoming Oncology Live CME Series virtual course on Innovative Care for Head and Neck Cancer: A 2024 Update of Changing Paradigms. April 10, 2024 5:30-6:30PM PT This course will provide an overview of current and emerging therapies for head and neck cancers, including new treatment paradigms incorporating immunotherapy as well as new treatment standards for radiation therapy and surgical treatment. This will include specific discussion of integration and sequencing of therapies in a multidisciplinary care model. Topics discussed will include: *Surgical therapy for oropharynx cancer. *De-escalation strategies for oropharynx cancer. *Alternatives to cisplatin for older and medically unfit patients with locoregionally advanced head and neck cancer. *Novel Therapeutics for Recurrent/Metastatic Head and Neck Squamous Cell Carcinoma. The target audience for this course includes medical oncologists, radiation oncologists, otolaryngologists, dentists, oral surgeons, advanced practice providers, nurses, students, residents and fellows. REGISTRATION IS FREE! To register, go to: https://lnkd.in/g8KaXDN3 #OncologyLiveCME #headandneckcancer #oropharynxcancer #oncology #oncologist #otolaryngology #otolaryngologist #dentist #oralsurgery #radiationoncology #radiationoncologist #meded #cme #cpdoffice
To view or add a comment, sign in
-
An insightful discussion on the latest advancements in Local-Regional Therapy for Liver Cancer with Professor Edward Kim on the "MedInsights Unleashed" podcast. Professor Edward Kim, MD FSIR delves into the crucial role of interventional radiology in treating liver cancer, highlighting the use of imaging-guided minimally invasive procedures for curative, palliative, and life-prolonging treatments. Key Insights from Professor Edward Kim: 🔹 Crucial Role of Interventional Radiology: Minimally invasive procedures guided by CT, MRI, and PET CT technologies play a pivotal role in liver cancer therapy. 🔹 Curative Intent Therapies: Thermal ablation and radiation segmentectomy with yttrium-90 are highly effective for early-stage hepatocellular carcinoma (HCC). 🔹 Multidisciplinary Approach: Collaborative care involving interventional radiologists, surgeons, oncologists, and hepatologists ensures shared decision-making and individualized treatment for each patient. 🔹 Advancements in Radioembolization: Yttrium-90 microspheres used in radioembolization have proven safe and effective, especially when combined with systemic therapies, showing promising outcomes. 📢 Stay Informed and Engaged Visit https://lnkd.in/eYEJiSJU to listen to this episode and much more to stay update with our latest content or follow us on #ApplePodcast #Spotify #iHeartRadio Click here to listen now: https://bit.ly/3VlfeRK 🌟 #LiverCancer #InterventionalRadiology #DownstagingforTransplant #MDT #yttrium-90 #HCC #CurativeIntent #MedicalPodcast
To view or add a comment, sign in
-
WSK Medical and UMCG receive the KWF Kankerbestrijding and Health~Holland grant to further enhance Zeno AI. The aim of the project is to translate the Integraal Zorg Akkoord into the care of head and neck cancer patients. The project aims to assist ENT specialists in the assessment of the pharynx and larynx close to the patient’s home by means of providing ENT specialists the expertise of head and neck surgeons and Zeno AI, to locally assess lesions in the head and neck area without sending patients to travel to the UMCG for this type of assessment. For more information on the project, please read the full press release here: https://lnkd.in/dwmpjcnd #telemedicine #headandneckcancer #zenoai #artificialintelligence #aiforhealthcare #ent
To view or add a comment, sign in
-
As a pathologist, collaborating with the oncology radiologist is a crucial aspect of the multidisciplinary approach in the management of oncology cases. This interdisciplinary cooperation allows for a comprehensive understanding of the patient's condition and ensures the optimal delivery of care. The radiologist's expertise in interpreting various imaging techniques, such as CT, MRI, and PET scans, can provide the pathologist with valuable insights into the tumor's size, location, and extent of involvement. This information can assist the pathologist in the selection of the most appropriate tissue sampling techniques and in the interpretation of the biopsy results. This collaborative approach allows for the integration of clinical, radiological, and pathological data, which can lead to more accurate diagnoses, better-informed treatment decisions, and improved patient outcomes. By working together, the pathologist and the oncology radiologist can contribute their unique expertise to the overall management of the oncology patient, ensuring that the patient receives the most effective and tailored care. #pathology #oncology #radiology #multidisciplinary BMC | Burjeel Medical City Burjeel Holdings Prof.Humaid Al-Shamsi MB(IRL),FRCP(Lon),FRCP(Ca),FRCP(Glasgow),FACP(US) Ibrahim Abu-Gheida
To view or add a comment, sign in
-
June scientific article now available to download: Title: Can AI predict survival from pre-treatment PET images for patients with oesophageal cancer? Author(s): Dr Nick Vennart Hospital: South Tyneside and Sunderland NHS Foundation Trust Oesophageal cancer is one of the leading causes of cancer death in the UK, with a 10-year survival rate of just 12%. Despite advances in diagnosis and curative treatment, the number of deaths from oesophageal cancer remains high, with over 50% of patients diagnosed with stage IV (incurable) disease. It is potentially curable with surgery but carries a significant risk of complication; the decision to treat is important for patients and clinicians. 18F-fluorodeoxyglucose PET (18F-FDG PETCT) is used as part of staging and is used where CT does not show metastatic disease in the liver or lungs. https://lnkd.in/eEc8andV #RADMagazine #medicalimaging #healthcare #medical #radiology #PET #nuclearmedicine #AI
To view or add a comment, sign in
-
🤝Another groundbreaking partnership with Gustave Roussy, the Europe’s premier cancer center and the fourth-best oncology hospital globally. This collaboration marks a significant milestone for Caresyntax and Relyens en France, solidifying our position as the leading provider of enterprise-scale #surgical technology data platforms in Europe. By combining Gustave Roussy's unparalleled expertise in cancer treatment and research with Caresyntax's cutting-edge surgical solutions, we are poised to revolutionize the way surgical care is delivered. Our shared goal is to harness the power of #data to make surgeries #safer, #smarter, and more efficient, ultimately enhancing patient outcomes and setting new standards in surgical safety and precision. This partnership is a testament to our dedication to innovation in Europe and France - and our belief in the power of technology to transform healthcare. 🌍 #Caresyntax #GustaveRoussy #DigitalSurgery #HealthcareInnovation #SurgicalSafety #TechnologyInHealthcare #PartnershipForTheFuture Bjoern von Siemens Dennis Kogan Peter Coudenys Alexandra Demirdjian Michael Schelper Matt Krueger Gargee Kashyap Julien Isman Lamija Pašalić Caresyntax
To view or add a comment, sign in
-
https://lnkd.in/db9S4ZZq Article title: The Need to Deepen the Abscopal Effect and Synergy among Radiotherapy and Immunotherapy Author(s): Denaro Nerina Journal: International Journal of Radiology and Radiation Oncology Journal ISSN: 2640-7566 Abstract: Emerging data that radiotherapy can potentially convert the patient’s own tumor into an in situ vaccine have raised significant interest for testing radiation in combination with immunotherapy. Moreover, the immune responses to localized irradiation may be the mediator of systemic effects (called the abscopal effect).The rapid growth of clinical investigations combining immunotherapy and radiotherapy (RT), in the absence of rigorous hypothesis-driven trial design, may fail to truly exploit the emerging new paradigms, which could impair further development of the field. With novel immunotherapies entering clinical practice at an accelerating pace the need to understand how to best integrate radiation biology with tumor immunology to provide a solid rationale for clinical translation remains urgent [1]. #XRayRadiography #Ultrasound #ComputedTomography #NuclearMedicine #Peertechz #PeertechzPublications #MagneticResonanceImagingMRI #PositronEmissionTomographyPET #RadiationOncology #ImagingSciences #BreastImaging #CardiovascularImaging #ChestRadiology #DiagnosticImaging #GastrointestinalImaging #GenitourinaryRadiology #Head #Neck #MusculoskeletalRadiology #NeuroimagingAndHeadAndNeck #NeuroRadiology #PediatricImaging #DiagnosticRadiology #InterventionalRadiology #RadiationPhysics #RadiationBiology #CardiopulmonaryImaging #GastrointestinalImaging #GenitourinaryImaging #MusculoskeletalImaging #Neuroradiology #HeadAndNeckImaging #NuclearMedicineAndMolecularImaging #PediatricImaging #VascularAndInterventionalRadiology #WomensImaging #ExternalBeamIrradiation #Brachytherapy #ParticleRadiationTherapy #IntraoperativeRadiationTherapy #StereotacticRadiosurgery #Radiotherapy #ExperimentalWorkInRadiobiology #TumorBiology #RadiationPhysics #Dosimetry #RadiationTreatmentPlanning
To view or add a comment, sign in
-
Addressing Challenges in Sarcoma Imaging and Finding Solutions in Clinical Trials In the dynamic landscape of oncology, the challenges posed by sarcomas and bone tumors spark the need for customized imaging solutions in clinical trials. These diverse tumors demand a sophisticated approach to imaging, emphasizing the significance of balancing advanced modalities with standardized criteria for robust clinical trial outcomes. 🧬 The diverse nature of sarcomas calls for a sophisticated imaging approach. In addition to CT, MRI including techniques such as DWI and DCE imaging provide crucial insights into tumor characteristics and treatment response. While traditional criteria like RECIST or Choi have limitations, incorporating modifications and clarifications or adding modalities like 18F-FDG PET offer a comprehensive view of tumor biology based on metabolic activity. These strategic improvements to clinical trial design enable a more effective approach to sarcoma clinical trials, bridging the gap between imaging and clinical outcomes. 📊 In addition to advanced MRI and PET, radiomics can be leveraged along with advanced computational methods for deeper insights into tumor biology and treatment response. 🔬 Imaging Endpoints leads the way in collaborating with scientists, investigators, radiologists and regulatory experts to implement modifications and clarifications to the imaging criteria by integrating cutting-edge modalities. Contact us at https://hubs.li/Q02HBTKZ0 to engage with our proficient medical and scientific affairs experts and explore tailored imaging solutions for your trials, emphasizing the significance of multi-modal approaches in shaping the future of sarcoma and bone tumor research. #ImagingEndpoints #MedicalImaging #ClinicalTrials #SarcomaImaging #OncologyResearch #TrialDesign
To view or add a comment, sign in
-
The United States offers a wide range of advanced treatment options for lung cancer, making it a leading destination for patients seeking high-quality care. Treatment approaches typically involve a combination of surgery, chemotherapy, radiation therapy, targeted therapy, and immunotherapy. The specific treatment plan is tailored to the individual patient's condition, including the type and stage of lung cancer, overall health, and personal preferences. Renowned cancer centers like the Mayo Clinic, MD Anderson Cancer Center, and Memorial Sloan Kettering Cancer Center are known for their expertise in lung cancer treatment. These institutions offer cutting-edge therapies, clinical trials, and access to the latest research advancements. Additionally, numerous other hospitals and clinics across the country provide comprehensive lung cancer care, including community hospitals with strong oncology programs. Get the best treatment for all types of cancer at the best hospitals in the USA. CONTACT MEDIPOCKET NOW!! www.medipocketusa.com . . . . #healthcare #health #medical #medicine #doctor #hospital #wellness #nurse #healthylifestyle #covid #doctors #healthyliving #nursing #healthy #pharmacy #surgery
To view or add a comment, sign in
3,358 followers